Arrowhead Pharmaceuticals Inc (ARWR)
22.11
+0.24
(+1.10%)
USD |
NASDAQ |
Apr 26, 16:00
22.11
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Return Price: 22.11 for April 26, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 25, 2024 | 21.87 |
April 24, 2024 | 23.29 |
April 23, 2024 | 23.78 |
April 22, 2024 | 23.92 |
April 19, 2024 | 22.33 |
April 18, 2024 | 22.61 |
April 17, 2024 | 22.53 |
April 16, 2024 | 23.67 |
April 15, 2024 | 24.01 |
April 12, 2024 | 24.70 |
April 11, 2024 | 25.68 |
April 10, 2024 | 25.39 |
April 09, 2024 | 26.25 |
April 08, 2024 | 25.70 |
April 05, 2024 | 25.78 |
April 04, 2024 | 26.11 |
April 03, 2024 | 26.48 |
April 02, 2024 | 26.19 |
April 01, 2024 | 28.24 |
March 28, 2024 | 28.60 |
March 27, 2024 | 28.70 |
March 26, 2024 | 27.84 |
March 25, 2024 | 27.89 |
March 22, 2024 | 27.21 |
March 21, 2024 | 28.23 |
Date | Value |
---|---|
March 20, 2024 | 28.16 |
March 19, 2024 | 27.77 |
March 18, 2024 | 28.14 |
March 15, 2024 | 28.28 |
March 14, 2024 | 27.42 |
March 13, 2024 | 28.59 |
March 12, 2024 | 28.55 |
March 11, 2024 | 29.40 |
March 08, 2024 | 33.45 |
March 07, 2024 | 33.20 |
March 06, 2024 | 35.40 |
March 05, 2024 | 34.08 |
March 04, 2024 | 35.11 |
March 01, 2024 | 36.08 |
February 29, 2024 | 32.10 |
February 28, 2024 | 34.00 |
February 27, 2024 | 31.16 |
February 26, 2024 | 30.49 |
February 23, 2024 | 31.60 |
February 22, 2024 | 30.20 |
February 21, 2024 | 29.18 |
February 20, 2024 | 29.22 |
February 16, 2024 | 29.48 |
February 15, 2024 | 29.57 |
February 14, 2024 | 29.63 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
17.43
Minimum
May 01 2019
90.47
Maximum
Feb 05 2021
44.35
Average
37.06
Median
Sep 03 2020
Total Return Price Benchmarks
Madrigal Pharmaceuticals Inc | 193.30 |
Viking Therapeutics Inc | 74.28 |
Akero Therapeutics Inc | 19.72 |
89bio Inc | 8.26 |
Sagimet Biosciences Inc | 4.07 |